Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder.

Psychiatry research - 30 Dec 2013

Cooper Alissa J, Narasimhan Sneha, Rickels Karl, Lohoff Falk W

Abstract excerpt

The pituitary adenylate cyclase-activating peptide (PACAP) and its receptor (PAC1) are involved in stress response and anxiety. Genotypes for PACAP/PAC1 were examined for effects on treatment response to venlafaxine XR in generalized anxiety disorder. The Asp54Gly (rs2856966) variant in the PACAP...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Anxiety Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclohexanols

Share to Drug Administration Schedule

Share to Neuropeptides

Share to Pharmacogenetics

Share to Pituitary Adenylate Cyclase-Activating Polypeptide

Share to Venlafaxine Hydrochloride

Source

Identifiers

PMID: 23972788
DOI: 10.1016/j.psychres.2013.07.038

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23972788-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder.PMID 23972788Read ↗

Circulating PACAP peptide and PAC1R genotype as possible transdiagnostic biomarkers for anxiety disorders in women: a preliminary study.Semantic proximity Read ↗

Genome-wide association study of treatment response to venlafaxine XR in generalized anxiety disorder.Semantic proximity Read ↗

Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.Semantic proximity Read ↗

Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor.Semantic proximity Read ↗

Association of NPSR1 rs324981 polymorphism and treatment response to antidepressants in Chinese Han population with generalized anxiety disorder.Semantic proximity Read ↗

Association of Posttraumatic Stress Disorder With rs2267735 in the ADCYAP1R1 Gene: A Meta-Analysis.Semantic proximity Read ↗

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.Semantic proximity Read ↗

Functional evaluation of a PTSD-associated genetic variant: estradiol regulation and ADCYAP1R1.Semantic proximity Read ↗

Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder.Semantic proximity Read ↗

Association analysis of the pituitary adenylate cyclase-activating polypeptide (PACAP/ADCYAP1) gene in bipolar disorder.Semantic proximity Read ↗

PACAP receptor gene polymorphism impacts fear responses in the amygdala and hippocampus.Semantic proximity Read ↗

Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.